Sort
21,281 grants matching “influenza”
Mechanisms of antiviral immunity and tolerance in the intestinal epithelium of Jamaican Fruit Bats
$214,575Diane Bimczok · Montana State University - Bozeman · R21 · FY2023 · AI
MECHANISMS OF TCDD PULMONARY IMMUNOTOXICITY
$214,543Washington State University · R01 · FY2003 · ES
RNA viruses of pandemic potential - viral infectivity
$214,525Emily A. Bruce · University Of Vermont & St Agric College · P20 · FY2025 · GM
Inference for interacting pathogens with mechanistic and phenomenological models
$214,505Nicholas G Reich · University Of Massachusetts Amherst · R21 · FY2015 · AI
Activating Latently Infected Cells Using Specific Antigens Including Those of HIV-1
$214,500John Guatelli · Veterans Medical Research Fdn/San Diego · R21 · FY2016 · AI
AIDS Vaccine Strategy Using IgG Transfer Pathway
$214,500Xiaoping Zhu · Univ Of Maryland, College Park · R21 · FY2007 · AI
Control of anti-viral B cell responses by IFNg, T-bet and Eomes
$214,452Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2015 · AI
Control of anti-viral B cell responses by IFNg, T-bet and Eomes
$214,452Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2018 · AI
Control of anti-viral B cell responses by IFNg, T-bet and Eomes
$214,452Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2016 · AI
Control of anti-viral B cell responses by IFNg, T-bet and Eomes
$214,452Frances E. Lund · University Of Alabama At Birmingham · R01 · FY2017 · AI
Interdisciplinary Training in Virology and Gene Therapy
$214,410Ren Sun · University Of California Los Angeles · T32 · FY2012 · AI
Human Health and 'Human Bulletins': Scientists and Teens Explore Health Sciences
$214,314Monique Renee Scott · American Museum Of Natural History · R25 · FY2011 · RR
New Vaccine Surveillance Network
$214,285John V Williams · University Of Pittsburgh At Pittsburgh · U01 · FY2016 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$214,285Janet A Englund · Seattle Children'S Hospital · U01 · FY2016 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$214,285Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2016 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$214,285Julie Anne Boom · Texas Children'S Hospital · U01 · FY2016 · IP
Enhanced Surveillance for Newly preventable Diseases (ARI and AGE Surveillance) Rochester, NY
$214,285Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2016 · IP
Kansas City - New Vaccine Surveillance Network (KC-NVSN)
$214,285Rangaraj Selvarangan · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2016 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$214,285Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2016 · IP
MOLECULAR ANALYSIS OF THE ANTIH INFLUENZAE RESPONSE
$214,163Scripps Research Institute · R01 · FY2000 · AI
Universal Influenza A Vaccine
$214,094Apovia, Inc. · R21 · FY2004 · AI
Human Metapneumovirus Infection in Adults
$213,886Ann R Falsey · University Of Rochester · R01 · FY2007 · AI
Project 1: Environmental Epidemiology of Autism
$213,876Irva Hertz-Picciotto · University Of California At Davis · P01 · FY2009 · ES
B. subtilis spore-delivered M2e-FP-based mucosal universal influenza vaccines
$213,750Lanying Du · New York Blood Center · R21 · FY2015 · AI
San Diego-Influenza Coverage Extension (SD-ICE)
$213,652Mark H Sawyer · University Of California, San Diego · U01 · FY2008 · IP